Furthermore, Rosewell Shaw et al. added another option to the previously mentioned strategy by engineering an OV that could secrete IL-12p70 in addition to the PD-L1-blocking antibody to promote the anti-tumor efficacy of CAR-T cell therapy for head and neck cancer. The gene discussed is CD274; the disease is neoplasm.